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Background: The well-known correlation between diet and physiology demonstrates the great possi-
bilities of food to maintain or improve our health, increasing the interest in ﬁnding new products with
positive physiological effects. Nowadays, one of the top research areas in Food Science and Technology is
the extraction and characterization of new natural ingredients with biological activity that can be further
incorporated into a functional food, contributing to consumer's well-being. Furthermore, there is a high
demand for effective encapsulation methodologies to preserve all the characteristics of bioactive com-
pounds until the physiological action site is reached.
Scope and approach: In this review, the relevance of developing standard approaches for the extraction of
the highly diverse bioactive compounds was described, as it deﬁnes the suitability of the following steps
of separation, identiﬁcation and characterization. Special attention was also dedicated to the encapsu-
lation techniques used on hydrophilic and/or lipophilic compounds (e.g., emulsiﬁcation, coacervation,
supercritical ﬂuid, inclusion complexation, emulsiﬁcation-solvent evaporation and nanoprecipitation).
Key ﬁndings and conclusions: Some useful conclusions regarding the selection of the best extraction
methodology (Soxhlet extraction, ultrasound-assisted extraction, supercritical ﬂuid extraction, acceler-
ated solvent extraction, or shake extraction) were achieved, considering important aspects such as cost,
required technical skills, extract integrity, green chemistry principles, solvent type, sample size, pH,
temperature and pressure. In addition, this comprehensive review allowed deﬁning the best protective
approach to solve the limitations related to the extremely low absorption and bioavailability of bioactive
phytochemicals, overcoming problems related to their low solubility, poor stability, low permeability and
metabolic processes in the GI tract.
© 2016 Elsevier Ltd. All rights reserved.; AP1, activator protein 1; APC, antigen presenting cell; ARE, antioxidant response elements; ASE, accelerated solvent
amin light scattering; ELK-1, [ETwenty-six (ETS)-like transcription factor 1]; EM, electron microscopy; ER, endoplasmic
; FDA, Food and Drug Administration; FOSHU, food for speciﬁc health use; GDP/GTP, guanosine di-/triphosphate; GI,
duced glutathione; HRE, hormone response elements; IP3, inositol trisphosphate; LDL, Low Density Lipoprotein; MAPK,
r of activated T cells; NF-kB, nuclear factor kappa-B; Nrf2, nuclear erythroid-derived 2-related factor; PIP2, phospha-
R, peroxisome proliferator activated receptor; RAF, rapidly activated ﬁbrosarcoma oncogene analog; RAR, retinoic acid
s; ROS, reactive oxygen species; RXR, retinoid X receptor; SFE, supercritical ﬂuid extraction; SNF, solid not fat; SOD,
ound assisted extraction; WHO, World Health Organization.
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Plants and their constituents have a key position in the pro-
gression of modern studies and knowledge on biological activity or
active substances. Plant species are important sources of food,
medicinal and supplementary health products, and their bioactive
compounds are themselves products of metabolism, acting in
similar ways to those operating in humans and animals (Gurib-
Fakim, 2006).
The emergency of dietary compounds with health beneﬁts of-
fers an excellent opportunity to improve public health (Chen,
Remondetto, & Subirade, 2006). Despite the dynamics of nutra-
ceutical substances in physiological functions is not yet fully un-
derstood, their addition in food matrices is acknowledged as
holding high potential to decrease disease risk. Accordingly, the
scientiﬁc community should provide the necessary bases to
develop innovative functional foods with the potential to produce
physiological beneﬁts or reduce the long-term risk of diseases
onset (Elliott & Ong, 2002).
The effectiveness of nutraceutical products in preventing dis-
eases depends on preserving the stability, bioactivity and
bioavailability of the active ingredients (Fang & Bhandari, 2010).
This represents a formidable challenge because only a small pro-
portion of molecules remains available after oral administration,
usually due to insufﬁcient gastric residence time, low permeability
and/or solubility in the gut, as well as instability under conditions
encountered in food processing or in the gastrointestinal (GI) tract
(Leonard, 2000).
Besides phytochemicals, probiotic delivery systems have also
been widely used with the main target of reinforcing the natural
intestinal ﬂora. These systems are usually categorized in conven-
tional (pharmaceutical formulations) and non-conventional
(mainly food-based) products. Their effectiveness in improving
the health status depends mainly on their ability to deliver viable
functional bacteria, overcoming the harsh effects of GI. Probiotics
have been increasingly used, but they present two sets of problems:
i) their size, and ii) the need to be kept alive (Champagne & Fustier,
2007). The delivery of these agents will therefore require food
formulations and production techniques to provide protective
mechanisms that maintain the active molecular form until the time
of consumption and its release in the physiological target within
the organism (Chen et al., 2006; Leonard, 2000). Once encapsulated
in a biodegradable polymer, cells are easier to handle than in a
suspension and their presence in microparticles can be quantiﬁed,
allowing the control of their dosage. In addition, their incorporation
enhances the survival of cells during processing and storage (Anal
& Singh, 2007).
Besides the beneﬁts of encapsulating living cells, incorporation
of bioactive compounds such as vitamins, prebiotics, bioactive
peptides, non-nutrient carotenoids, phenolic compounds, phy-
toestrogens, glucosinolates, phytosterols, fatty acids or structured
lipids into food systems, provides away to develop novel functional
foods that may have physiological beneﬁts or reduce the disease'
risk (Chen et al., 2006).
1.1. Bioactive compounds isolated from plants
Since the beginning of mankind, people use plants for their
nutritional purposes. However, after discovering their medicinal
properties, ﬂora became a useful source of compounds with
important roles in preventing/treating diseases and health
improvement in several geographical locations. Actually, the
ancestral use of herbal plants might be considered as the basis for
using naturally bioactive molecules. In addition, the World Health
Organization (WHO) predicts that 80% of the world populationdepends on traditional medicine as primary healthcare, mainly
through the use of plant extracts and their bioactive compounds
(Azmir et al., 2013).
All living things, from the bacterial cell to the millions of cells in
plants, produce chemicals for their survival and livelihood. The
compounds produced by biological systems are usually divided in
two distinct groups: i) primary metabolites - chemical substances
(e.g., carbohydrates, amino acids, proteins and lipids) essential for
cell maintenance, growth and development; ii) secondary metab-
olites - substances with low-molecular-weight (e.g., phenolic acids,
alkaloids or terpenes) relevant to increase the overall surviving and
protection ability, by interacting with their surroundings (Azmir
et al., 2013; Scalbert & Williamson, 2000). The production of sec-
ondary metabolites in different species depends on their growth
process and the particular requirements of the species. Several
studies have shown that the production of secondary metabolites
depends also on the climate, soil and crop conditions (for instance,
plants growing in harsh environments produce a greater number of
antioxidants) (Azmir et al., 2013). Furthermore, and independently
of the raw material, the qualitative and quantitative studies of
bioactive compounds from plant materials depend mostly on the
selection of proper extraction methods. These methods are usually
affected by common factors, such as the matrix properties of the
botanical source, solvent, temperature, pressure and time
(Hernandez, Lobo,&Gonzalez, 2009). The extraction conditions are
so determinant, that the bioactive plant compounds might be
classiﬁed according to the type of extraction: i) hydrophilic or polar
compounds (e.g., phenolic acids, ﬂavonoids, organic acids, sugars);
ii) lipophilic or nonpolar compounds (e.g., carotenoids, alkaloids,
terpenoids, fatty acids, tocopherols, steroids). Another common
classiﬁcation criterion is categorizing the bioactive plant com-
pounds according to their distribution in nature: i) shortly
distributed (simple phenols, pyrocatechol, aldehydes); ii) widely
distributed (ﬂavonoids, phenolic acids); and iii) the least abundant
polymers (tannin and lignin) (Bravo, 1998; Sanchez-Moreno,
2002).
In general, bioactive compounds of plants might be deﬁned as
secondary metabolites that cause pharmacological or toxicological
effects in human and animals, which can be identiﬁed and char-
acterized from extracts of roots, stem, bark, leaves, ﬂowers, fruits
and seeds (Bernhoft, 2010).
In the next section, special attention will be given to the
particular cases of phenolic compounds and sterols, which repre-
sent two of the main classes of phytochemicals with a proven track
of success as ingredients in functional foods formulations.
1.1.1. Phenolic compounds
Phenolic compounds are plant secondary metabolites
commonly found in plants and derived products such as berries,
apples, citrus fruit, cocoa, grapes, onions, olives, tomatoes, broccoli,
lettuce, soybeans, grains and cereals, green and black teas, coffee
beans and red and white wines (Birt, Hendrich, & Wang, 2001). It
has been estimated that about 8000 compounds naturally occur-
ring in plants are phenols (Arceusz, Wesolowski, & Konieczynski,
2013). Their characteristic structural feature is an aromatic ring
with varying hydroxyl-substitutions. Despite occurring in free
form, these compounds appear mainly in their bound forms, for
example as glycosides or esters (Morton, Caccetta, Puddey, & Croft,
2000). Phenolic compounds might be produced from two distinct
pathways: i) shikimic acid (phenylpropanoids); ii) acetic acid
(phenols) (Sanchez-Moreno, 2002). According to their carbon
chain, phenolic compounds can be divided in 16 major classes
(Table 1). These compounds have diverse biological activity, being
mainly acknowledged for their preventing action against the
damage caused by oxidative stress. Other relevant functions in
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attractive colour of leaves, fruits and ﬂowers, providing resistance
against pesticides and predators, controlling germination, growth
and reproduction processes. Due do their several physiological
roles, phenolic compounds are essential for the major cellular
metabolism processes (Dicko, Gruppen, Traore, Voragen, & van
Berkel, 2006).
Phenolic acids have a benzene ring, a carboxylic group and one
or more hydroxyl and/or methoxyl groups, being usually divided in
two groups: i) benzoic acids; ii) hydroxycinnamic acids. The ben-
zoic acids have seven carbon atoms (C6eC1), while hydroxycin-
namic acids have nine carbon atoms (C6eC3), but the most
commonly found in vegetables present seven carbon units (Yang,
Landau, Huang, & Newmark, 2001), where they are rarely found
in the free form (commonly present as esteriﬁed compounds).
Phenolic acids may be about one-third of the phenolic compounds
in the human diet, where these substances have a high antioxidant
activity (Bravo, 1998; Giada, 2013).
Flavonoids are the most common and widely distributed group
of plant phenolic compounds. Their general structure, as phenyl-
propanoid derivatives, consists of a ﬁfteen-carbon skeleton with
two benzene rings linked via a heterocyclic pyran ring (Fig. 1). They
comprise a large class of plant secondary metabolites with relevant
action on the plant defence system, having been reported as
important constituents of the human diet (Giada, 2013).
The chemical nature of ﬂavonoids depends on their structural
class, according to the degree of methylation, hydrogenation and
hydroxylation and other substitutions and conjugations. Flavonoids
can be divided into a variety of classes such as: ﬂavones, ﬂavanols,
ﬂavonols, ﬂavanonols, ﬂavanones, isoﬂavones or anthocyanins
(Table 2) (Kumar & Pandey, 2013; Scalbert & Williamson, 2000)
with different antioxidant, antibacterial, antiviral and anticancer
activities (Giada, 2013; Kumar & Pandey, 2013). Flavonoids occur
mainly as aglycones, but they exist also as glycosides and methyl-
ated derivatives (Kumar & Pandey, 2013; Scalbert & Williamson,
2000). These compounds have attracted interest due to the dis-
covery of their pharmacological activities and health regulation
function. Regarding their biological activity, they were previously
reported as having antioxidant, hepatoprotective, antibacterial,
anti-inﬂammatory, anticancer and antiviral effects, besides inhib-
iting lipid peroxidation (Gurib-Fakim, 2006). Furthermore, ﬂavo-
noids can act as growth regulators in plants (Kumar & Pandey,
2013). When added to food products, ﬂavonoids are responsible
for preventing fat oxidation and protecting vitamins and enzymes,
while also contributing for food colour and taste. The absorption of
dietary ﬂavonoids, which occurs mainly in the small intestine, de-
pends on their physiochemical properties. The aglycone form is
easily absorbed, while the glycosylated molecules need to suffer a
previous deglycosylation step. After absorption, ﬂavonoids are
conjugated in the liver or metabolized to smaller compounds
(Kumar & Pandey, 2013).
Tannins are another well-known example of phenolic com-
pounds with intermediate to high molecular weight. These com-
pounds are usually classiﬁed in two major groups: i) hydrolysable
tannins; ii) non-hydrolysable tannins or condensed tannins (Chung,
Wong,Wei, Huang,& Lin,1998). Hydrolysable tannins have a centre
of glucose or a polyhydric alcohol partially or completely esteriﬁed
with gallic acid or hexahydroxydiphenic acid, forming gallotannin
and ellagitannins (Table 1) (Okuda, Yoshida, & Hatano, 1995).
Condensed tannins are polymers of catechin and/or leucoantho-
cyanidin that constitute the main phenolic fraction responsible for
the characteristic astringency of the vegetables. These substances
are polymeric ﬂavonoids that form the anthocyanidins pigments
(Stafford, 1983). Although the antioxidant activity of tannins has
been less reported than the activity of ﬂavonoids, recent researchstudies have shown that the degree of polymerization is related
with the antioxidant activity - in condensed and hydrolysed tan-
nins of high molecular weight, this activity can be up to 15e30
times superior to that attributed to simple phenols (Sanchez-
Moreno, 2002).
As it would be easily anticipated, considering the diverse bio-
logical activity of phenolic compounds, their incorporation into
food products is largely studied. Some of the most relevant exam-
ples include meat and ﬁsh products, pasta (Day, Seymour, Pitts,
Konczak, & Lundin, 2009), ice cream, cheese, yogurt and other
dairy products (Çam, Içyer, & Erdogan, 2014; Caleja et al., 2015;
Karaaslan, Ozden, Vardin, & Turkoglu, 2011).
1.1.2. Sterols
Phytosterols, which include plant sterols and stanols (Jones &
AbuMweis, 2009), are currently among the most successful phy-
tochemicals for the development of functional foods with unique
health claims (Gurib-Fakim, 2006). They are a member of the tri-
terpene family of natural products and are important structural
components of plant membranes to stabilize phospholipid bilayers
in plant cell membranes, just as cholesterol does in animal cells.
These components occur naturally in plants, mainly in free and
esteriﬁed forms (de Smet, Mensink,& Plat, 2012), being included in
the nonsaponiﬁable fraction of plant oil (Jones & AbuMweis, 2009).
This family includes more than 200 different phytosterols andmore
than 4000 other types of triterpenes (Moreau, Whitaker, & Hicks,
2002).
Structurally, phytoesterols are similar to cholesterol and
contain 28 or 29 carbons and one or two CeC double bonds,
typically one in the sterol nucleus and sometimes a second in the
alkyl side chain (Barreira & Ferreira, 2015). They are not synthe-
tized in humans, being also poorly absorbed and excreted faster
from the liver than cholesterol. When incorporated as a functional
food ingredient, plant sterols and stanols are frequently esteriﬁed
with a fatty acid ester to increase the solubility in the food matrix
(Jones & AbuMweis, 2009; de Smet et al., 2012). Furthermore, di-
etary phytosterols were reported as inhibiting the uptake of both
dietary and endogenously produced cholesterol on the intestinal
cells and several studies suggest a protective role of phytosterols
against colon, prostate and breast cancer (Jones & AbuMweis,
2009).
Phytosterols have been included in several food matrices with
different degrees of effectiveness. While their incorporation in
chocolate, orange juice, cheese, non-fat beverages, meats, crois-
sants and mufﬁns, oil in bread and cereal bars did not allow great
results (considered as cholesterol lowering), when added to fat
spreads, mayonnaise, salad dressings, milk and yoghurt, the ob-
tained results were more satisfactory (Jones & AbuMweis, 2009).
1.2. Probiotics, prebiotics and lactic products
Due to their availability in different formulations, lactic products
are one of the top examples of functional foods. Based on their
mechanism of action, lactic fermentation products are usually
classiﬁed in three groups (Mitsuoka, 2014): i) probiotics: viable
microorganisms such as lactobacilli and biﬁdobacteria that beneﬁt
the host by improving the intestinal bacterial balance; these live
microbial feed supplements associate naturally with the intestinal
mucosa, improving the intestinal microbial balance. Because of
their perceived health beneﬁts, probiotic bacteria have been
increasingly incorporated into a range of products including yo-
gurts, cheeses, ice cream, milk powders and frozen dairy desserts
(Brannon-Peppas, 1995; Desmond et al., 2005); ii) prebiotics: non-
digestible food ingredients, such as oligosaccharides and dietary
ﬁbre, that selectively stimulate the growth or activities of useful
Table 1
Basic structures of some common phenolic compounds.
Class Basic
skeleton
Basic structure
Simple phenols C6
Benzoquinones C6
Phenolic acids C6eC1
Acetophenones C6eC2
Phenylacetic acids C6eC2
Hydroxycinnamic
acids
C6eC3
Phenylpropenes C6eC3
Coumarins C6eC3
Chromones C6eC3
Naphthoquinones C6eC4
Xanthones C6eC1eC6
(continued on next page)
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Table 1 (continued )
Class Basic
skeleton
Basic structure
Stilbenes C6eC2eC6
Anthraquinones C6eC2eC6
Flavonoids C6eC3eC6
Lignans (C6eC3)2
Ellagitannins (C6eC3)n
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nutrients to probiotic bacteria. Basically, prebiotic are non-
digestible carbohydrates, mainly obtained by extraction from
plants, followed by enzymatic hydrolysis (Gurib-Fakim, 2006); iii)
biogenics: biologically active molecules such as peptides, ﬂavo-
noids and carotenoids, that favour the host by direct immunosti-
mulation, suppression of mutagenesis, tumorigenesis, peroxidationor intestinal putrefaction.
Probiotics and prebiotics improve the balance of the intestinal
microbiota by enhancing the growth of beneﬁcial bacteria and
inhibiting the development of harmful bacteria (immunostimula-
tion), besides inducing the production of biogenics such as anti-
bacterial substances and immunopotentiators (Mitsuoka, 2014).
While the positive effects of the oral ingestion of bacteria have been
Fig. 1. General structure of ﬂavonoids and basic structures of some of the most common subgroups.
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above gut-speciﬁc functions and immunological functions leading
to the belief that probiotics have functional beneﬁts at both cellular
and molecular levels (Panigrahi et al., 2007). In fact, the use of
probiotics may cause cell-mediated immune responses and treat-
ments for several human intestinal dysfunctions (Kalliom€aki,
Salminen, Poussa, Arvilommi, & Isolauri, 2003). Furthermore,
these agents have the potential to act as delivery systems for vac-
cines and prevent the conditions caused by pathogenic organisms
in the intestine. The ability of probiotic microorganisms to survive
andmultiply in the host strongly inﬂuences their beneﬁts. Probiotic
bacteria, besides the immunological effects and the prevention,
protection and eradication of pathogenic bacteria, have been linked
to cancer therapy, besides having been found to be therapeutic in
patients with high cholesterol levels (Govender et al., 2014).
The bacteria associated to these functions, which mainly belong
to Lactobacillus and Biﬁdobacterium genera (Table 3), have several
typical characteristics: metabolic stability, adherence to the intes-
tinal cell walls, not promoting antibiotic resistance, non-
pathogenic, being safe for consumption and effective in providing
health beneﬁts. In addition, these bacteria should be active in the
product, survive along the upper digestive tract, resist to the gastric
acid bile, oxygen and enzymes, being able to co-aggregate as part of
the natural gut ﬂora and have beneﬁcial effects after adhering to
the intestine of the host (Govender et al., 2014; Mitsuoka, 2014).
However, there are still several problems regarding the low
viability of probiotic bacteria in dairy foods, which might be
severely affected by different factors, including pH, dissolved oxy-
gen concentration, storage temperature, species and strains of
associative fermented dairy product organisms. Therefore, several
approaches designed to increase the resistance of these probiotics
have been proposed, including an appropriate selection of acid and
bile resistant strains, stress adaptation, incorporation of micro-
nutrients and microencapsulation (Gismondo, Drago, & Lombardi,
1999).
In fact, there are many systems for the delivery of probiotics to
the GI system, which are categorized in two groups: i) non-
conventional commercial formulations, consisting mainly of food-
based-products (cheeses, yogurts, creams, chocolates, milk and
meat, among others), many of which produced using probiotic
bacteria; ii) conventional pharmaceutical systems (e.g., beads,capsules and tablets), usually more effective in this regard and
more well-characterized, comparing to commercial food-based-
carrier systems. Each type of formulation has been found to
possess advantages in the delivery of probiotics, with each one
showing differences in their effectiveness to deliver the correct
amount of bacteria to the human intestinal system as well as in
providing protection to the dosed probiotic bacteria (Govender
et al., 2014).
2. Extraction of bioactive compounds
The high variability of bioactive compounds demands devel-
oping suitable standard approaches for their extraction. In fact, the
quality of the further steps of separation, identiﬁcation and char-
acterization of bioactive compounds is highly dependent on the
suitability of the extraction process. All available techniques are
aimed at common objectives such as extracting target compounds,
increasing the selectivity of analytical methods and the sensitivity
of the forwardly performed bioassay, converting the bioactive
compounds into more suitable forms for detection and separation
and providing a strong and reproducible method (Chester,
Pinkston, & Raynie, 1996).
Some of the most applied methods include:
i) Soxhlet extraction, usually with hexane, petroleum ether,
ethyl acetate, or methanol; this methodology allows per-
forming several extractions cycles with “renewed” solvent,
but the process is too long and the solvents are costly. This
methodology is usually employed to extract the lipophilic
components, using hexane or petroleum ether as solvents.
However, it might also be used for polar compounds, as in
the case of speciﬁc phenolic compounds which proved to be
effectively extracted with methanol (Arceusz et al., 2013).
Recently, it was also applied to extract volatile compounds
(Wu, Wang, Liu, Zou, & Chen, 2015).
ii) Ultrasound-assisted extraction (UAE), based in using ul-
trasonic vibrations toward an extracted sample. Despite be-
ing highly dependent on the type of solvent, sample size, pH
of extract, temperature and pressure, it is fast, simple and
allows extracting several samples simultaneously; it is often
performed with methanol, acetone, water and ethyl acetate.
Table 2
Main classes of ﬂavonoids.
Flavonoid Basic structure Examples
Flavones Acacetin, apigenin, baicalein, chrysin, diosmetin, luteolin, scutellarein, tangeritin.
Flavonols Azaleatin, ﬁsetin, galangin, kaempferol, morin, myricetin, quercetin, rhamnetin.
Flavanols Catechin, epichatechin, epigallocatechin, proanthocyanidins, theaﬂavins, thearubigins.
Flavanones Butin, eriodictyol, hesperetin, homoeriodictyol, isosakuranetin, naringenin, pinocembrin, sakuranetin,
sterubin.
Flavanonols Astilbin, taxifolin.
Isoﬂavones Biochanin A, daidzein, genistein, glycitein, prunetin, puerarin, formononetin.
Anthocyanins Cyanidin, delphinidin, malvidin, pelargonidin, peonidin, petunidin
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Table 3
Microorganisms applied in fermented milks, lactic milk drinks, pasteurized sour
milk and lactic fermentations products.
Lactobacillus Biﬁdobacterium Other species
L. acidophilus
L. amylovarus
L. casei
L. crispatus
L. delbrueckii ss. bulgaricus
L. gallinarum
L. gasseri
L. johsonii
L. paracasei
L. plantarum
L. reuteri
L. rhamnosus
B. adolescentis
B. animalis
B. biﬁdum
B. breve
B. infantis
B. lactis (animalis)
B. longum
B. thermophilum
B. pseudolongum
Enterococcus faecalis
Enterococcus faecium
Lactococcus lactis
Leuconostoc mesenteroides
Sporolactobacillus inulinus
Streptococcus thermophilus
Clostridium butyricum
Bacillus cereus var. toyoi
Escherichia coli Nissle
Saccharomyces cerevisiae
Saccharomyces boulardii
B. Vieira da Silva et al. / Trends in Food Science & Technology 50 (2016) 144e158 151This technology has been successfully applied to extract
different bioactive compounds such as carotenoids, poly-
saccharides, proteins, phenolic compounds, aromatic com-
pounds or sterols (Vilkhu, Mawson, Simons, & Bates, 2008;
Villares, García-Lafuente, Guillamon, & Ramos, 2012; Wu
et al., 2015).
iii) Supercritical ﬂuid extraction (SFE), usually performed with
carbon dioxide under high pressure, allows working with
low temperatures, high selectivity, low solvent volume, small
samples, short extraction times and automation; neverthe-
less, its effectiveness is affected by several parameters such
as pressure, temperature, time and solubility (Arceusz et al.,
2013). The ﬁrst application of SFE to foodstuff dates back
from the early 1970s, when this technique was used in the
decaffeination of coffee beans. Afterwards, when SFE was
recognized as a “green” procedure, its application was
boosted and several nutraceutical ingredients, e.g., carot-
enoid pigments, sterols, tocopherols, or polyphenolic com-
pounds were extracted using this methodology (Srinivas &
King, 2010).
iv) Accelerated solvent extraction (ASE), is made with the
same solvents, but using higher pressure and elevated tem-
peratures, presenting the additional advantages of enabling
the extraction of fresh samples, shorter extraction times,
higher automation and good extraction kinetics. Several
types of compounds have been extracted with this tech-
nique, but some of the most commonly reported include
vitamins (J€apelt & Jakobsen, 2016), phenolic compounds
(Arceusz et al., 2013; Nayak et al., 2015) and carotenoids
(Saha, Walia, Kundu, Sharma, & Paul, 2015).
v) Shake extraction, in this type of extraction, a shaking device
is used, allowing more effective extractions and shortening
the required time. The main advantage of this technique is
the increase in the surface are where the solvent interacts
with the plant material. The high variety of shaking devices
or available solvents make it suitable for a high diversity of
components. However, there is a relevantly higher number of
reports describing its application to extract phenolic com-
pounds (Arceusz et al., 2013).3. Development of functional foods from plant bioactive
compounds
3.1. Functional foods
Despite the lack of an exact deﬁnition for functional foods
(except in Japan, where the concept Food for Speciﬁc Health Use,FOSHU, is well established), the following working deﬁnition: “A
functional food is, or appears similar to, a conventional food. It is part
of a standard diet and is consumed on a regular basis, in normal
quantities. It has proven health beneﬁts that reduce the risk of speciﬁc
chronic diseases or beneﬁcially affect target functions beyond its basic
nutritional functions.” stands as the most generally accepted (Doyon
& Labrecque, 2008). Accordingly, it is possible to say that a given
food might be considered as functional when, besides its nutri-
tional effects, it exerts one or more target functions in the body,
thereby improving health status or minimizing disease risk. The
American Dietetic Association (ADA), in 2004, suggests that the
“term functional food should not be used to imply that there are
good and bad foods ( … ) all food can be incorporated into a
healthful eating plan, the key being moderation and variety”.
Several organisations accept that functional foods are “foods or
ingredients of foods that provide an additional physiological
beneﬁt beyond their basic nutrition” (ILSI, 1999).
It is important to distinguish functional food from nutraceutical.
In practical terms, functional foods are foods or beverages with a
speciﬁc effect (scientiﬁcally veriﬁed), whereas nutraceuticals may
be produced from foods, being characterized as bioactive compo-
nents obtained from a functional food with a well-deﬁned activity
and marketed in concentrated form as pills, capsules, powders,
tinctures etc. either as single or mixed preparations (Gurib-Fakim,
2006). Nutraceuticals were also deﬁned as dietary substances
that deliver a concentrated form of a bioactive substance in quan-
tities that exceed those obtained from food (Govender et al., 2014).
The market for functional ingredients and foods has experi-
enced an amazing growth in recent years due to the increased
consumers' awareness and the interest in promoting healthy diets
and lifestyle. The development of functional foods that promote
health beyond providing basic nutrition is on the rise, as food
manufacturers increase their offer to consumers' needs. Most
functional foods' research has focused on nutritional composition
of the food and, to a lesser extent, on the product quality and effects
of adding food texture enhancers. Functional ingredients, such as
puriﬁed bioactive compounds or concentrated extracts from nat-
ural sources, can be successfully incorporated into foods, providing
novel functional product categories and new commercial oppor-
tunities. However, the additional challenge of ensuring that func-
tional ingredients survive, remaining active and bioavailable after
food processing and storage, endures. In addition, the appearance
and sensory properties of foods are the most important attributes
to the consumer, prior to the nutritional value. From a
manufacturing point of view, the most popular functional food
product should be relatively easy to formulate and process (Day
et al., 2009).
It is well established that food components contribute to
physiologic and biologic well-being. Functional foods are thought
to generate such useful effects as bio-regulation of appetite, bio-
defence (including immunity and suppression of allergies), pro-
phylaxis against hypertension, diabetes, cancer,
hypercholesterolemia, anaemia and platelet aggregation
(Mitsuoka, 2014).
3.2. Biochemistry of functional ingredients
Multiple modes of action on key targets have been proposed for
the beneﬁcial effects of natural bioactive compounds, including
antioxidant function and anti-inﬂammatory functions, modulation
of signal transduction and gene expression, leading to the induction
of apoptosis and necrosis. The functional compounds naturally
present in plants have been proposed to exert their biological ac-
tion through several mechanisms: i) direct free radical scavenging;
ii) downregulation of radical production through elimination of
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involved in reactive oxygen species (ROS) production; iv) elevation
and protection of endogenous antioxidants; v) modulation of signal
transduction systems and mitochondrial function. In the case of
polyphenols, their antioxidant activity is a result of their peroxi-
dation chain breaking ability (Jacob et al., 2012).
Besides lowering the expression of enzymes (e.g., xanthine ox-
idase) involved in ROS generation, antioxidants might also upre-
gulate the expression of antioxidant enzymes, such as glutathione
peroxidase (GPX), catalase (CAT) and superoxide dismutase (SOD)
or enhance the synthesis of reduced glutathione (GSH) (Du, Guo, &
Lou, 2007).
Antioxidants have multiple modes of action. Polyphenols con-
taining ortho-dihydroxy groups, for instance, have been found to
stimulate the transcription of genes encoding the antioxidant en-
zymes through the Keap1/Nrf2/ARE pathway, which is a prime
target for cancer chemoprevention and a potential target for pre-
venting neurodegenerative diseases and enhancing longevity, since
the generation of ROS is a critical initiating factor in these pro-
cesses. Another mode of action is the modulation of the tran-
scription nuclear erythroid-derived 2-related factor (Nrf2) that
controls the expression of several genes associated with cytopro-
tection, including antioxidant enzymes, xenobiotic-metabolizing
enzymes (phase 2 enzymes), metal-chelating enzymes, drug
transporters, and molecular chaperones (Hayes, McMahon,
Chowdhry, & Dinkova-Kostova, 2010). In fact, the expression of
cytoprotective enzymes, e.g., glutathione-S-transferase (GST) or
nicotinamide adenine dinucleotide phosphate-H quinone oxido-
reductase (NQO1), is a common feature of cancer-preventive mol-
ecules (particularly, diphenols and phenylpropanoids). The
efﬁciency of induction of NQO1 was considered to be linearly
correlated with their ability to release an electron in a two-step
process: i) oxidation of diphenols into quinones, and ii) oxidation
of thiol groups in Keap1 involved in Nrf activation (Jacob et al.,
2012).
Other molecules, such as sulphoraphane or curcumin, contain
Michael acceptor functionalities (oleﬁn or acetylene structures
conjugated to electron withdrawing groups) as well as phenolic
hydroxyl groups (with higher efﬁciency if located in ortho posi-
tions) that can scavenge ROS or nitrogen-centered free radicals.
This is a key pathway involved in cytoprotection from ROS and
inﬂammation and helps to prevent the development of chronic
degenerative diseases (Jacob et al., 2012).
The results obtained in several studies suggest that natural
functional ingredients act through multiple mechanisms that
enhance their in vivo efﬁcacy. Thus, it is becoming increasingly clear
that phytochemicals, including polyphenols, carotenoids, and
several others, as well as their physiological metabolites, may exert
their beneﬁcial action through multiple functional modes
(Williams, Spencer, & Rice-Evans, 2004).
3.3. Bioaccessibility and bioavailability of functional ingredients
Functional ingredients can be absorbed by an active process or
through passive diffusion across the membrane. More complex
structures have to be broken during digestion, before the active
ingredients can be absorbed. The molecular characteristics of
nutraceuticals have great inﬂuence on their absorption, often
explaining their limited uptake and extremely low physiological
levels (Lipinski, Lombardo, Dominy, & Feeney, 2012).
Accordingly, bioavailability of nutrients and bioactive com-
pounds present in plant products is an extremely important area of
food and nutrition research. Food and Drug Administration (FDA)
deﬁned bioavailability “as the rate and extent to which the active
substances contained in a drug are absorbed and become available atthe site of action”. It is usually measured in the blood plasma and is
affected by many factors, including the processing technique, in-
dividual variability and physiological state dose. Apart from pro-
cessing itself, the presence of other food components in the
ingredients, also affects the bioavailability of nutrients (Failla, Huo,
& Thakkar, 2008). Accordingly, it is essential to develop predicting
in vitro digestion methods that can be useful tools for screening the
factors and components that modify the bioavailability of bioactive
compounds in a given matrix composition, allowing selecting the
formulation conditions that achieve the highest availability
(Fernandez-García, Mínguez-Mosquera, & Perez-Galvez, 2007).
The concept of bioaccessibility is slightly different, since it cor-
responds to the amount of an ingredient/nutrient that is available
for absorption in the gut after digestion (Hedren, Mulokozi, &
Svanberg, 2002). In either case, bioaccessibility and bioavailability
of a nutrient are determined by the physical properties of the food
matrix. Even in natural foods, bioaccessibility of the bioactive
compounds that characterize the product may decrease due to
other interfering components of the diet (Fernandez-García,
Rincon, & Perez-Galvez, 2008).
4. New protected-delivery technologies in functional foods
preparation
The main objective of protected-delivery technologies is pre-
serving the core material from adverse environmental conditions
(e.g., light, oxygen, or pH), promoting a controlled liberation of the
encapsulate, determining the rates of the carried bioactive com-
pounds and, ultimately, how much is absorbed into the body (the
overall efﬁcacy of the compounds). These techniques can be applied
to reduce the reactivity with the environment, protect the core
material from degradation, modify some characteristic to allow
easier handling, mask unpleasant ﬂavours or odours, dilute the core
material when only a small amount is required, or provide barriers
between the sensitive bioactive materials (Anal & Singh, 2007;
Champagne & Fustier, 2007; Desai & Park, 2005). Brieﬂy, their
major advantage is the ability to control the release rate of the
incorporated materials and deliver them to the right place at the
right time (Sch€afer et al., 1992).
4.1. Microencapsulation
Microencapsulation is a process by which a core (i.e., a bioactive
or functional ingredient) is packaged within a secondary material
to form a microcapsule. This secondary material, known as the
encapsulant, matrix or shell, will form a protective coating or ma-
trix around the core, isolating it from its surrounding environment
until its release is triggered, avoiding undesirable interactions of
the bioactive ingredient with other food components or chemical
reactions that could lead to its degradation, possible undesirable
consequences on taste and odour, as well as negative health effects
(de Vos, Castenmiller, Hamer, & Brummer, 2006).
Microcapsules are small vesicles semipermeable, spherical, with
thin and strongmembranes surrounding a solid or liquid core (Anal
& Singh, 2007). Many morphologies can be produced for encap-
sulation, but two major morphologies are more commonly seen:
mononuclear capsules with a single core involved by a shell and the
aggregates with many cores embedded in a matrix (Schrooyen, van
der Meer, & De Kruif, 2001).
The design of a microencapsulated ingredient requires knowl-
edge of (1) the core, (2) the encapsulant materials, (3) interactions
between the core, matrix and the environment, (4) the stability of
the microencapsulated ingredient in storage and when incorpo-
rated into the food matrix and (5) the mechanisms that control the
release of the core. Despite several ingredients are suitable to be
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and processing costs are expensive (Anal & Singh, 2007; de Vos
et al., 2006).
The encapsulant materials can be a pure compound or a mixture
(sugars, gums, proteins, natural and modiﬁed polysaccharides,
lipids and synthetic polymers), which are also called coating ma-
terial, wall material or capsule membrane (Gibbs, Kermasha, Alli, &
Mulligan,1999). Thesematerials are generally selected from a range
of proteins, carbohydrates, lipids and waxes (Table 4), depending
on the properties of the core to be encapsulated and the purpose of
microencapsulation. They are typically ﬁlm forming, pliable,
odourless, tasteless and non-hygroscopic. Solubility in aqueous
media or other speciﬁc solvents and/or ability to exhibit a phase
transition (such as melting or gelling) might be useful (Sanguansri
& Augustin, 2010).
Among them, protein-based micro-particles have found wide
applications in the food industry, because they can be precisely
designed for use in many food formulations and virtually any
ingredient can be encapsulated, whether hydrophobic, hydrophilic,
or even from microbial origin (Chen et al., 2006).
Carrageenan has also been widely used. This natural poly-
saccharide, extracted from marine algae, requires a high tempera-
ture to be dissolved at concentrations ranging from 2 to 5% (Klein&
Vorlop, 1985). Alginic acid might also form natural polymers, which
are profuse in the cell walls of brown algae. Due to alginate'
biocompatibility and simple gelation with divalent cations such as
Ca2þ, it is widely used for cell immobilization of cultured cells and
encapsulation. Cellulose acetate phthalate has also been increas-
ingly used because it is physiologically inert when administered,
besides having awide range of pH values inwhich it is soluble (Anal
& Singh, 2007). Another well-known encapsulating polymer is
chitosan, which is a linear polysaccharide composed of b-(1e4)-
linked D-glucosamine and N-acetyl-D-glucosamine with increasing
importance in the food ﬁeld because of its unique biocompatibility,
non-toxicity and biodegradability (Anal & Stevens, 2005).
The starch that is not digested by pancreatic amylases in the
small intestine can also be used to ensure the viability of probiotic
populations in the intestine and also offers robustness and resil-
ience to environmental stresses (Crittenden et al., 2001).
Independently of the encapsulating material, the release of the
core depends on the formulation used to obtain the desired
structure or the accurate size control. Particles may thus consist of a
core composed of one to several types of ingredients surrounded by
a wall or barrier of uniform or non-uniform thickness either single-
layered or multi-layered. Matrix degradation, and consequently the
release of contents, can thus be controlled to occur at different
times. Larger particles generally release encapsulated compounds
more slowly and over longer periods, while particle size reductionTable 4
Materials commonly used as encapsulants for food application purposes (Sanguansri
& Augustin, 2010).
Carbohydrates Proteins Lipids and waxes
Native starches
Modiﬁed starches
Resistant starches
Maltodextrins
Dried glucose syrups
Gum acacia
Alginates
Pectins
Carrageenan
Chitosan
Cellulosic materials
Sugars and derivatives
Sodium caseinate
Whey proteins
Isolated wheat proteins
Soy proteins
Gelatins
Zein
Albumin
Vegetable fats and oils
Hydrogenated fats
Palm stearin
Carnauba wax
Bees wax
Shellac
Polyethylene glycolintroduces several bio-adhesive improvement factors, including
increased adhesive force and prolonged GI transit time, leading to a
higher drug bioavailability (Pothakamury & Barbosa-Canovas,
1995).
There are several types of foods functionalized using micro-
encapsulated carriers. According to their share in functional food
market, the most relevant examples are i) dairy products, ii) cereal
products and healthy bars, iii) beverages (mainly vitamin- and
mineral-enriched drinks and weight-control beverages), iv) fats
and oil products (particularly, spreads with cholesterol-lowering
phytosterols, healthy oils, sauces and dips with nutraceutical in-
gredients); and v) bakery products (Sanguansri & Augustin, 2010).
A wide variety of techniques are used for encapsulation. In
general, three steps are involved: i) the formation of the wall
around the material to be encapsulated; ii) assuring that undesired
leakage does not occur; iii) ensuring that unwelcome materials are
kept out (Gibbs et al., 1999).
The technologies available to encapsulate active ingredients are
usually classiﬁed as mechanical (emulsiﬁcation, spray-drying,
ﬂuidised-bed coating, centrifugal extrusion, spinning disks, pres-
sure extrusion and hot-melt extrusion) or chemical (ionotropic
gelation, simple or complex coacervation, solvent evaporation,
liposome entrapment or cyclodextrin complexation) processes
(Augustin & Hemar, 2009; Champagne & Fustier, 2007; Sanguansri
& Augustin, 2010).
Some of the presently used technologies include:
i) Spray drying e typically used for the preparation of dry and
stable food additives and ﬂavors, this is the most widely used
microencapsulation technique, mainly for being economical,
ﬂexible and suitable to be performed as a continuous oper-
ation. This process is based in the injection of a liquid sus-
pension of the bioactive product at the top of a vessel which
dries the droplet into a ﬁne powder particle in conjunction
with hot air; the liquid droplet solidiﬁes and entraps the
bioactive product (Champagne & Fustier, 2007). The wall
material represents a relative disadvantage of this method-
ology, since it must be soluble in water; modiﬁed starches,
maltodextrin or gums are usually used as the wall materials.
The produced particles are typically spherical (10e100 mm in
diameter) (Fang & Bhandari, 2010). This technique allows
adding multiple coating layers besides providing a high
protection to short exposure periods to acids, humidity and
oxygen; however, cells are released at slow rates (low tem-
peratures) and the phase separation in coating is lipid-based
(Champagne & Fustier, 2007).
ii) Freeze dryinge also called lyophilisation or cryodesiccation,
this process is useful for a wide variety of heat-sensitive in-
gredients (Oetjen & Haseley, 2008). Encapsulation by freeze
drying is achieved when the core materials homogenize in
the initial solution and then co-lyophilizes, originating
irregular particles. The long dehydration period is commonly
seen as a disadvantage, but this technique is suitable to
encapsulate water-soluble essences and natural aromas, as
well as drugs. Nevertheless, the improvement in the stability
or bioactivity of the core materials was sometimes reported
as insufﬁcient (Fang & Bhandari, 2010).
iii) Coacervation e this methodology is based on the phase
separation of the hydrocolloids present in an initial solution
and the further deposition of the newly formed coacervate
around the suspended or emulsiﬁed bioactive ingredient
(Gouin, 2004). Coacervation encapsulation, particularly
when achieved with more than one colloidal solute did not
usually allows obtaining particles with deﬁnite forms, be-
sides being considered as an expensive method. However, it
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ingredients (e.g., polyphenols). The wall materials are usually
composed of gelatins or glucan (Fang & Bhandari, 2010).
iv) Liposome entrapment e These colloidal particles consist of
a lipid membranous system (lipid bilayer) encapsulating a
hydrophilic space, which makes them appropriate to
encapsulate water-soluble, lipid-soluble, and amphiphilic
ingredients. Despite the variety of liposome production
techniques, the underlyingmechanism is generally the same,
being triggered by the hydrophilicehydrophobic interaction
between phospholipids and water. The most relevant
advantage of this technique is the possibility of controlling
the release rate and exact point of delivery of the incorpo-
rated materials (Fang & Bhandari, 2010). Bioactive agents
encapsulated into liposomes are protected from the diges-
tion in stomach, promoting their bioavailability and bioac-
tivity. The nature of the core material affects the efﬁciency of
liposome encapsulation, which can be promoted by adding
ethanol to the preparation solution (Fang, Lee, Shen, &
Huang, 2006).
v) Cocrystallization e in this process, the structure of sucrose
(in the form of a supersaturated syrup) is modiﬁed (120 C,
95e97 Brix) from a perfect to an irregular agglomerated
crystal. If a bioactive ingredient is added before this spon-
taneous crystallization, it will be incorporated in the void
spaces of the porous matrix of the newly formed microsized
crystals (Chen et al., 2006). Besides improving the solubility,
homogeneity, dispersibility, hydration, anticaking, stability
and ﬂowability of the encapsulated materials, this technique
allows converting liquid materials into powders, which
might convey beneﬁts for applications in the pharmaceutical
industry (Fang & Bhandari, 2010).
vi) Yeast-encapsulation e this approach uses yeast cells
(Saccharomyces cerevisiae) as the encapsulating material,
being usually applied to essential oils, ﬂavours and poly-
phenols. The core ingredients must be able to pass freely
across the cell wall and passively remain inside the cells. The
yeast cells are also expected to be able of controlling the
diffusion of the incorporated ingredients, using a preselected
temperature and time, while the cell wall should prevent the
evaporation, extrusion and oxidation of the core material.
This technique is entangled with green chemistry principles,
as it uses no additives besides water, yeast and core in-
gredients. Furthermore, it has a low cost and allows pro-
cessing high volumes of bioactive ingredients (Blanquet
et al., 2005).
vii) Cold gelation e this recent method provides an alternative
way to develop protein micro particles in the food industry.
No organic solvents are required for this method, and
encapsulation is achieved under mild conditions, thereby
minimizing destruction of sensitive nutraceutical com-
pounds. More importantly, globular proteins (e.g., whey
proteins) have the ability to denature, dissociate, and
aggregate under different conditions of pH, ionic strength,
and temperature (Champagne & Fustier, 2007).
Several efforts are also being directed to integrate molecules of
interest in hydrogels. A hydrogel is a water-swollen network of
hydrophilic polymers that can swell in water and hold a large
amount of water, while maintaining a network structure (Qiu &
Park, 2012). These particles are known for their functionality and
ability to tune physical properties in industrial applications such as
controlled drug delivery, cosmetics, pharmaceuticals and foods
(Çam, Içyer, & Erdogan, 2014; Caleja et al., 2015; Stokes, 2011; Tan,
Tam, Lam, & Tan, 2005). Although successful as oral drug deliverysystems, one of the limitations of these hydrogels for food appli-
cations is their high content in components not generally recog-
nized as safe for regular consumption. Hence, there is a tendency
towards using food proteins to develop environment sensitive
hydrogels to deliver nutraceuticals. In fact, the exposure of multiple
functional groups within the protein upon denaturing might be
exploited to create different interactions between nutraceutical
compounds and polypeptide chains. The ability of hydrogels made
from proteins to entrap both fat-soluble and water-soluble food
components should also contribute to the development of inno-
vative functional solid foods (Chen et al., 2006).
A fundamental advantage of the hydrogels is that nutraceutical
carrier gels can stabilize food texture, which is a highly desirable
characteristic in the manufacturing of food products (Shewan &
Stokes, 2013). In fact, we can refer to various advantages of
micro-hydrogels suspensions: their capacity to modify their own
volume in response to changes in solvent quality and properties
(Stokes, 2011); the possibility to remove harmful volatile organic
compounds; enabling fat reduction; decreasing energy density of
foods (Sagis et al., 2008); reducing sedimentation during transport
and storage; or stabilising emulsion droplets (Hedges, 2012). Since
micro-hydrogel particles possess a colloidal state, it allows them to
be designed to have long-range attractive forces, which can cause
aggregation and ﬂocculation using a small volume. Furthermore,
the volume of the micro-hydrogel suspension might be increased,
either by adding a high percentage of micro-hydrogels, as well as
inducing swelling by a change in the pH or in the solvent (Shewan
& Stokes, 2013). Also, the micro-hydrogel suspensions do not
possess the non-linear viscoelasticity typical from other polymer
solutions, offering an alternative to obtain desired shear thinning
and yield stresses without undesirable elastic properties (Stokes,
2011).
Moreover, the presence of acidic and basic groups in poly-
peptide chains allows modulating the release rate of molecules
from protein gels according to pH variations (Qiu & Park, 2012).
There are several methods of manufacturing micro-hydrogels
and the suitability depends on the hydrocolloid or polymer car-
rier as well as the functionality and particle size distribution. There
are three major techniques to manufacture micro-hydrogels: i)
monomer; ii) polymer; iii) macro-gel. For synthetic micro-
hydrogels the starting point is usually a monomer, while for
biopolymer micro-hydrogels it is usually the polymer or macro-gel
(Shewan & Stokes, 2013).
4.2. Nanoencapsulation
The techniques used for nanoencapsulation are more complex
than for microencapsulation, mainly due to the intricate
morphology of the capsule and core material and the demand in
controlling the release rate of the nanoencapsulates. Nano-
encapsulation involves the incorporation, absorption or dispersion
of bioactive compounds and the formation of functional materials
encapsulated in small vesicles at a length scale of less than 100 nm
(Reis, Neufeld, Ribeiro, & Veiga, 2006). Nanoparticles provide a
greater surface area and increased solubility, enhancing bioavail-
ability due to their subcellular size and improved controlled release
(Mozafari et al., 2008). They can extend the compound' residence
time in the GI tract by decreasing the inﬂuence of intestinal clear-
ance mechanisms and increasing the surface available to interact
with the biological support (Arbos, Arangoa, Campanero, & Irache,
2002; Brannon-Peppas, 1995). They can also penetrate deeply into
tissues through ﬁne capillaries, cross the epithelial lining fenes-
tration (e.g., in the liver) and are generally taken up efﬁciently by
cells (Desai, Labhasetwar, Amidon, & Levy, 1996), thus allowing
efﬁcient delivery of active compounds to target sites in the body.
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they are relatively easy to prepare and their size distribution can be
monitored to increase the circulation time in the GI tract. Protein
nanoparticles could be internalized by cells and degraded to release
the nutraceutical content, signiﬁcantly improving bioavailability
while avoiding undesired toxic side effects of the free compound
(Li, Jiang, Xu, & Gu, 2015).
Two strategic approaches are currently used to produce nano-
particles: i) top down approach that involves the application of
precise tools in which big structures are contracted by breaking up
bulk materials, allowing the size reduction and shaping of the
structure for the desired application with energy input; ii) bottom
up approach, which allows structures to be built from small mol-
ecules that are capable of self-assembly and self-organization and
aggregation to form nanoparticles. These nanoencapsulation
techniques can be used for encapsulation of various hydrophilic
and lipophilic bioactive compounds (Augustin& Sanguansri, 2009).
Nanoparticles can interact with the components by hydrogen
bonds and hydrophobic interactions (Li et al., 2015), being settled
with hydrophobic groups inside and polar groups on surface of
particles, which allow them to remain stable due to their inter-
particle repulsions and hydration (Li et al., 2015).
There is a number of mechanisms that allow the control of the
size and characteristics of nanoparticles. Dynamic light scattering
(DLS) and electron microscopy (EM) are some of those techniques.
DLS evaluates the particle size and size distribution, while EM
measures size and morphology of dry particles (Bootz, Vogel,
Schubert, & Kreuter, 2004).
Cyclodextrins (CDs) are extensively used as additives to increase
the solubility of poorly water-soluble organic compounds by the
formation of an inclusion complex (Chakraborty, Basu, & Basak,
2014). This family of cyclic oligomers compounds might be pro-
duced from the transformation of starch by enzymatic conversion
(Jeang, Lin, & Hsieh, 2005). CDs are empty capsules of sugar mol-
ecules bound together in a ring with six, seven or eight glucose
residues that can include a great variety of molecules in its cavity;
the external part is hydrophilic and the internal is hydrophobic
(Astray, Gonzalez-Barreiro, Mejuto, Rial-Otero, & Simal-Gandara,
2009). Some years ago, CDs were considered poisonous substances.
However, nowadays we know that they are not only nontoxic, but
they are also used in food and can be helpful for protecting ﬂavours,
vitamins and natural colours. In fact, CDs have been used as addi-
tives such as solubilizers, to stabilize ﬂavours and fragrances, to
eliminate undesired tastes, to improve the physical and chemical
properties or to enhance the bioavailability of poorly soluble drugs
(Del Valle, 2004). Once again, the core material inﬂuences the
effectiveness of the technique. Here, the higher the hydrophobicity
and the smaller the molecule, the greater the afﬁnity for CDs (Fang
& Bhandari, 2010).
The production of CDs is divided into four steps: i) the culture of
the microorganism that produce the cyclodextrin glucosyl trans-
ferase enzyme, separation, concentration and puriﬁcation of the
enzyme from the fermentation environment; ii) the enzymatic
conversion of pre-hydrolysed starch in mixture of dextrins fol-
lowed by separation of CDs from the mixture; iii) puriﬁcation and
iv) crystallization (Astray et al., 2009; Mazzobre, Elizalde, dos
Santos, Ponce Cevallos, & Buera, 2010)). The puriﬁcation of a- and
g-CDs increases considerably the cost of production; so, for eco-
nomic reasons, 97% of the CDs used in market are b-CDs, and this
isomer has the lowest water solubility of all CDs (Astray et al.,
2009).
Flavour plays an important role in the satisfaction of the con-
sumer and several times the manufacturing and storage process of
materials and ingredients cause modiﬁcations in ﬂavour by
reducing aroma compound intensity or producing off-ﬂavourcomponents (Astray et al., 2009). The addition of b-CDs as stabi-
lizing or thickening agents could retain some aroma compounds in
food matrices during thermal processes (Jouquand, Ducruet, &
Giampaoli, 2004). In fact, of all encapsulating techniques, molecu-
lar encapsulation of ﬂavours with b-CDs is the most effective for
providing protection against heat and evaporation. Overall, CDs
reduce residual organic volatile contaminants in packaging mate-
rials, improve barrier properties of the package materials, improve
sensory properties and maintain food quality and safety (Astray
et al., 2009).
The high suitability of b-CDs is clearly emphasised by the di-
versity of food products already functionalized using this tech-
nique. Some of the most well-known include fruit juices, wheat
ﬂour, low-cholesterol cheese, low-cholesterol butter, low-
cholesterol eggs, beer, chocolate, tea and seed oils (Mazzobre
et al., 2010).
4.3. Emulsions
An emulsion is a mixture of at least two immiscible liquids,
usually oil and water, where one of the liquids is dispersed as small
spherical droplets in the other. Emulsions are turbid, with droplet
sizes ranging from 0.2 to 10 mm and may remain stable for a
considerable period of time, despite being, in general, thermody-
namically unstable systems (Anton, Benoit, & Saulnier, 2008).
Emulsion technique is applied to bioactive compounds in aqueous
solutions to stabilize the interfacial layer between the dispersed
and continuous phase which has been created by adding energy to
the system (Flanagan & Singh, 2006).
Emulsions can be classiﬁed according to the spatial organization
of the oil and water phases: i) oil/water emulsionwhen oil droplets
are dispersed in an aqueous phase; ii) water/oil emulsion when the
water droplets are dispersed in an oil phase; iii) several other
mixtures between the previous (Benichou, Aserin, & Garti, 2004).
Microemulsions are systems comprising a mixture of water,
hydrocarbons and amphiphilic compounds which form kinetically
and thermodynamically stable compounds, transparent, homoge-
neous and isotropic solutions with particle sizes ranging from 5 to
100 nm (Paul & Moulik, 1997). Some of the macroscopic charac-
teristics that should be controlled include viscosity, conductivity
and dielectric measurements (Mackeben, Müller, & Müller-
Goymann, 2001). Microemulsions are formed from the sponta-
neous self-assembly of the hydrophobic and hydrophilic compo-
nents of surfactant molecules, having numerous applications in
pharmacy, cosmetics and in foods (Flook, Cameron, &Wren, 2004).
However, in foods, the use of microemulsions is limited by the
types of surfactants which are used to facilitate microemulsions
formation, because many surfactants are not permitted in foods
(Flanagan & Singh, 2006).
Nanoemulsions, also known as ﬁne dispersed emulsions and
submicron emulsions, are not as thermodynamically stable as in
the case of microemulsions (Tadros, Izquierdo, Esquena, & Solans,
2004). They are produced by microﬂuidization or micelle forma-
tion techniques (Champagne & Fustier, 2007) and exhibit poor
solubility and low bioavailability (Flanagan & Singh, 2006). The
mechanical processes that generate nanomeric emulsions include
the drop creation, the deformation and disruption of macrometric
initial droplets, followed by the surfactant adsorption at their
interface to insure the steric stabilization (Anton et al., 2008). The
main particularity of nanoemulsions, making them prime candi-
dates for nanoparticle engineering, is the great stability of the
droplet suspension (Anton et al., 2008).
The industrial application of emulsions is increasing. “Func-
tional emulsions” is an US patent name for polyphenols dissolved in
ethanol, which are thenmoved with vegetable oil in a homogenizer
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(Nakajima Nabetani, Ichikawa, & Xu, 2003).
The main products functionalized with emulsions as incorpo-
ration carriers include milk, yogurt, vegetable oils, mayonnaise,
fruit juices and ice cream (Fustier, Taherian, & Ramaswamy, 2010).5. Conclusions
The beginning of the third millennium is being characterized by
an increasing life expectancy and a great coverage of health-related
issues by the media. Generally, consumers are more interested in
new food products, whose functions go beyond the nutritional and
sensory role, having also potential beneﬁts over the physiological
functions, ultimately controlling and preventing diseases. In this
context, overall preferences are moving towards products that are
capable of producing metabolic and physiological effects, ensuring
health and wellbeing by restoring the balance of intestinal ﬂora,
counteracting the oxidative stress or stimulating the immune
response. Considering the present marketing demands and tech-
nological obstacles to overcome, the future development of func-
tional foods will probably include: i) improving the solubility of
lipophilic compounds in high moisture beverages; ii) stabilising
sensitive compounds such as vitamins, ﬂavors, essential oils or
unsaturated fatty acids; iii) preserving the physical characteristics
of a foodstuff under stress conditions like freezing, thawing,
microwaving, blanching, or pasteurising; iv) prevent oxidation
processes.
A well-accepted fact is that the effectiveness of nutraceutical
products depends on the maintenance of the stability, bioactivity
and bioavailability of their active ingredients. Thereby, the delivery
of these agents requires food formulations and production pro-
cesses able to maintain the active molecular structures until their
consumption and release in the physiological target. Accordingly,
besides developing more effective methods of extraction and
characterization of the properties of functional foods, it is imper-
ative to include protective methodologies (microencapsulation,
nanoencapsulation and emulsions), before incorporating bioactive
ingredients into functional foods. As previously explained, inde-
pendently of the encapsulating material, the release of the core
ingredient will depend on the formulation used to obtain the aimed
structure or the accurate size.
The development of novel foodstuffs is particularly challenging,
because the cornerstone aspects of product safety, preparation
mode and sensory quality, cannot be hampered by the incorporated
bioactive compounds. In addition, besides selecting the bioactive
molecule, it is essential to assure a suitable delivery proﬁle,
considering biodegradability and biocompatibility concerns. In fact,
there is not an ideal delivery system, since each of the available
ones has its advantages and limitations. Even so, some transversal
principles should be considered in the design of innovative food
products: i) checking regulatory issues for the permission of using
the bioactive molecule and encapsulating material; ii) knowing the
physical state in which the product should be prepared; iii) taking
into account the conditions it must undergo throughout its pro-
cessing, storage and consumption; iv) deﬁning the moment and
form bywhich it should be added during the production process; v)
anticipating possible interactions with other food ingredients.
Another important consideration to bear in mind is the need to
adopt a multidisciplinary approach. In fact, when the theme is food,
we can never forget that the accurate knowledge of the food
microstructure and how it might improve consumers' health
should always go along with a high level of creativity and taste-
fulness. This is undoubtedly the right way to achieve successful
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